Shore Bancshares, Inc. (SHBI) — Q1 2022 Form 10-Q
Reporting period: Three months ended March 31, 2022; balance-sheet comparisons are with December 31, 2021. Financial statements are unaudited. The results include Severn Bancorp, acquired October 31, 2021, so year-over-year comparisons reflect a larger combined company.
Key financial and operating metrics
| Metric | Q1 2022 | Comparable period / change |
|---|---|---|
| Net interest income | $22.4 million | $13.8 million in Q1 2021 |
| Noninterest income | $6.0 million | $2.6 million in Q1 2021 |
| Noninterest expense | $20.3 million, including $0.7 million merger costs | $10.5 million in Q1 2021 |
| Provision for credit losses | $0.6 million | $0.4 million in Q1 2021; a $1.7 million reversal in Q4 2021 |
| Net income / diluted EPS | $5.6 million / $0.28 | $4.0 million / $0.34 in Q1 2021 |
| Cash from operating activities | $25.2 million | $3.9 million in Q1 2021 |
| Cash and cash equivalents | $571.0 million | Down $12.6 million from year-end |
| Total assets / stockholders’ equity | $3.49 billion / $351.9 million | Assets up from $3.46 billion; equity up $1.2 million |
| Loans held for investment, net | $2.17 billion | Up $61.2 million from year-end |
| Total deposits | $3.07 billion | Up $42.3 million from year-end |
| Total borrowings | $52.9 million | Down from $57.0 million at year-end |
Margins and capital: Management’s discussion reports a Q1 net interest margin of 2.78%, down from 3.00% in Q1 2021 and 2.87% in Q4 2021; the detailed average-balance table instead reports 2.76%. Management estimates the margin would have been 3.07% without approximately $400 million of excess liquidity. At March 31, the Company’s total risk-based capital ratio was 14.86% and the Bank’s was 14.21%; respective leverage ratios were 8.33% and 9.14%.
Material changes and management commentary
- Net interest income rose year over year, primarily reflecting higher average loan balances and the Severn acquisition. Average loans increased $684.9 million year over year; organic legacy loans excluding PPP loans grew $111.9 million, or 7.2%, from year-end.
- Net income increased year over year, but diluted EPS fell from $0.34 to $0.28 as weighted average shares increased from 11.7 million to 19.8 million, largely reflecting the Severn transaction.
- Noninterest income increased $3.5 million year over year, with mortgage-banking revenue of $1.9 million and title-company revenue of $0.3 million among the new or expanded sources. Higher staffing, benefits, occupancy, data processing and acquired-intangible amortization contributed to increased expenses.
- Available-for-sale securities recorded an unrealized loss of $2.2 million after tax in other comprehensive income; accumulated other comprehensive loss was $2.2 million at quarter-end. Held-to-maturity securities had a reported fair value $16.6 million below amortized cost. Management attributed securities losses to interest-rate movements, not credit concerns, and said it did not intend or expect to be required to sell the securities before recovery.
- Cash declined mainly because of $61.2 million in net loan growth and a $10.1 million purchase of bank-owned life insurance. The Bank also cited $15 million in correspondent-bank federal-funds lines, marketable investments and FHLB capacity as liquidity sources.
Outlook, risks and contingencies
- The filing provides no specific earnings, revenue, margin or loan-growth guidance. Management cautions that quarterly results are not necessarily indicative of full-year results.
- Credit quality indicators included $2.8 million of nonaccrual loans and $3.9 million of nonperforming assets; nonperforming assets increased from $3.0 million at year-end. The allowance for credit losses was $14.7 million, or 0.67% of loans. Management said it considered the allowance adequate.
- Commercial real estate is a significant concentration: commercial real estate loans were 42.6% of loans and construction loans 11.8%. Non-owner-occupied commercial real estate, including construction, was 291.4% of risk-based capital; that portfolio had grown 101.4% over three years. The Company warns this concentration may require heightened risk management or additional capital and could affect shareholder returns.
- The Company provides services to medical-use cannabis businesses that are legal under Maryland law but remain illegal under federal law. Related deposits were about $54.2 million and loans $35.2 million; no amount was accrued for potential federal action. Management states that enforcement could disrupt these services and expose the Company to legal action, fines or other consequences.
- Outstanding commitments to extend credit and letters of credit totaled $471.2 million. Management said current litigation was not expected to materially affect the Company. The filing identifies interest-rate changes, Severn integration, credit estimates and the pending adoption of credit-loss accounting standards as matters to monitor. CECL adoption was expected for fiscal years beginning after December 15, 2022; the Company was still assessing the impact.
Important facts for investors to verify
- Resolve the reported net interest margin discrepancy: 2.78% in the MD&A narrative versus 2.76% in the average-balance table.
- Assess how Severn’s acquired balances, merger expenses and increased share count affect comparisons and per-share earnings.
- Monitor CRE concentration, loan growth, nonaccrual loans and allowance assumptions as economic and interest-rate conditions change.
- Review the sensitivity and potential consequences of securities valuation declines, particularly the unrealized loss on held-to-maturity holdings.
- Evaluate the federal-law exposure from cannabis-related customers and the scale and funding implications of off-balance-sheet commitments.